Amgen (NASDAQ: AMGN)
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-08-02 | ||||||
REV |
Q1 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 4.150 | 4.250 | 0.1000 | ||||
REV | 6.110B | 6.238B | 128.000M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Amgen (NASDAQ: AMGN) through any online brokerage.
Other companies in Amgen’s space includes: Legend Biotech (NASDAQ:LEGN), Exact Sciences (NASDAQ:EXAS), Sarepta Therapeutics (NASDAQ:SRPT), Neurocrine Biosciences (NASDAQ:NBIX) and Ionis Pharmaceuticals (NASDAQ:IONS).
The latest price target for Amgen (NASDAQ: AMGN) was reported by Mizuho on Tuesday, May 10, 2022. The analyst firm set a price target for 208.00 expecting AMGN to fall to within 12 months (a possible -14.71% downside). 26 analyst firms have reported ratings in the last year.
The stock price for Amgen (NASDAQ: AMGN) is $243.87 last updated May 16, 2022, 8:00 PM UTC.
A quarterly cash dividend of $1.94 per share of Class A Common Stock. The quarterly cash dividend was payable on June 8, 2022 to stockholders of record on May 16, 2022.
Amgen’s Q2 earnings are confirmed for Tuesday, August 2, 2022.
There is no upcoming split for Amgen.
Amgen is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.